(Q36837156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Intranasal vaccines for protection against respiratory and systemic bacterial infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author

Maria Leonor S. Oliveira

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Ana Paula Mattos Arêas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Paulo Lee Ho

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

419-429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

Pneumococcal vaccines: an update on current strategies.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Appropriateness of a Pneumococcal Conjugate Vaccine in Brazil: Potential Impact of Age and Clinical Diagnosis, with Emphasis on Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Pertussis resurgence: diagnosis, treatment, prevention, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Bordetella pertussis from functional genomics to intranasal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Prospects for vaccine prevention of meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

A universal vaccine for serogroup B meningococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

New generation of mucosal adjuvants for the induction of protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Bacterial ghosts as antigen delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Bacterial spores as vaccine vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

New tools for antigen delivery to the MHC class I pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Development of improved vectors for DNA-based immunization and other gene therapy applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

M cell-targeted DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Use ofLactococcus lactisExpressing Pili from Group BStreptococcusas a Broad‐Coverage Vaccine against Streptococcal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

Nasal boost with adjuvanted heat-killed BCG or arabinomannan–protein conjugate improves primary BCG-induced protection in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.419

21 January 2018

Identifiers

DOI

10.1586/14760584.6.3.419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17542756%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference